Figure 2

Kaplan Meier analysis of event-free survival during follow-up in patients discriminated with the presence of late gadolinium enhancement (LGE) on cardiovascular magnetic resonance (CMR) (A), with LGE volume of ≥ 17% (B), with the presence of segmental wall motion abnormality (SWMA) (C), and with left ventricular ejection fraction (LVEF) of < 50% (D). In the patient cohort with preserved LVEF (≥50%), the absence of SWMA (30 patients) resulted in no events during follow-up, while 17 patients with SWMA were still at risk with 4 events (E).